GLP-1 receptor agonists in Parkinson’s disease: a meta-analysis revealing motor benefit and highlighting mood improvement - Top-Institutions - MDSpire

GLP-1 receptor agonists in Parkinson’s disease: a meta-analysis revealing motor benefit and highlighting mood improvement

  • By

  • Yutong Chen

  • Zhehao Zhang

  • Zheng Liu

  • Tingting Lv

  • Mengfei Ye

  • Junwei Yan

  • Min Zhang

  • July 3, 2026

  • 0 min

Share

Top Institutions in Neurology

Brief introduction explaining scope and methodology.

  • #1

    University College London
    University College London

    London, UK

    Key Differentiators

    • Neurology
    • Movement Disorders

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, Maryland

    Key Differentiators

    • Neurology
    • Movement Disorders

  • #3

    Stanford University
    Stanford University

    Stanford, California

    Key Differentiators

    • Neurology

  • #4

    Columbia University Irving Medical Center
    Columbia University Irving Medical Center

    New York, New York

    Key Differentiators

    • Neurology

  • #5

    University of Eastern Finland
    University of Eastern Finland

    Kuopio, Finland

    Key Differentiators

    • Neurology

Original Source(s)

GLP-1 receptor agonists in Parkinson’s disease: a meta-analysis revealing motor benefit and highlighting mood improvement

  • by Yutong Chen, Zhehao Zhang, Zheng Liu, Tingting Lv, Mengfei Ye, Junwei Yan, Min Zhang

  • July 3, 2026

Related Content

Development and external validation of a 90-day mortality prediction model for comatose sepsis patients: impact of cerebrovascular disease and dementia

Age-stratified multimodal MRI and machine learning to explore autism-related brain characteristics in youth

Exercise-conditioned extracellular vesicles in Alzheimer’s disease: a multi-organ signaling network linking peripheral adaptation to brain pathology